ChengDa Pharmaceuticals Co. Ltd. (301201) — Capital Reinvestment Ratio
ChengDa Pharmaceuticals Co. Ltd. (301201) has a Capital Reinvestment Ratio of 10.00x as of December 2024, meaning it reinvests 10% of its operating cash flow (CN¥28.65 Million) in capital expenditures (CN¥286.36 Million). See how much free cash does ChengDa Pharmaceuticals Co. Ltd. generate to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
ChengDa Pharmaceuticals Co. Ltd. Capital Reinvestment Ratio (2019–2024)
This chart tracks ChengDa Pharmaceuticals Co. Ltd.'s Capital Reinvestment Ratio across 6 annual periods.
Annual Capital Reinvestment Ratio for ChengDa Pharmaceuticals Co. Ltd. (2019–2024)
Year-by-year Capital Reinvestment Ratio for ChengDa Pharmaceuticals Co. Ltd. from 2019 to 2024. For live market cap and broader valuation context, see 301201 market cap.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 10.00x | CN¥28.65 Million | CN¥286.36 Million | ▲ +754.6% |
| 2023 | 1.17x | CN¥192.07 Million | CN¥224.67 Million | ▼ -72.9% |
| 2022 | 4.32x | CN¥47.67 Million | CN¥205.69 Million | ▲ +158.7% |
| 2021 | 1.67x | CN¥83.14 Million | CN¥138.70 Million | ▲ +237.2% |
| 2020 | 0.49x | CN¥128.97 Million | CN¥63.81 Million | ▼ -34.6% |
| 2019 | 0.76x | CN¥67.52 Million | CN¥51.06 Million | — |